Skip to main content
Clinical Trials/ACTRN12617000354381
ACTRN12617000354381
Completed
未知

An investigation examining the efficacy and safety of a multi-nutrient intervention on symptoms of antenatal depression and anxiety in pregnant women who are symptomatic: A double blind, randomized, controlled trial

Professor Julia Rucklidge0 sites88 target enrollmentMarch 8, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
Depression
Sponsor
Professor Julia Rucklidge
Enrollment
88
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 8, 2017
End Date
January 10, 2021
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Professor Julia Rucklidge

Eligibility Criteria

Inclusion Criteria

  • 1\) women aged 16 years and over; 2\) 12\-24 weeks gestation; 3\) low risk singleton pregnancy; 4\) free from psychiatric medication for four weeks; 5\) score of 13 or more on the Edinburgh Postnatal Depression Scale (EPDS); 6\) deemed reliable and compliant with the protocol.
  • Reference group inclusion criteria:
  • 1\) pregnant women aged 16 years and over; 2\) low risk singleton pregnancy

Exclusion Criteria

  • 1\) regular vomiting; 2\) high risk pregnancy; 3\) significant pregnancy complications; 4\) known foetal abnormalities; 5\) serious current or historical medical condition; 6\) known allergy to the ingredients of the intervention; 7\) known metabolic condition such as Wilson’s disease, hemochromatosis.; 8\) untreated or unstable thyroid disease; 9\) known neurological disorder; 10\) desire to continue taking prenatal supplements that either exceed the upper limit or are not required for medical purposes (decisions discussed and made on a case\-by\-case basis)

Outcomes

Primary Outcomes

Not specified

Similar Trials